|

Mirabegron Clinical Trials

2 actively recruiting trials across 1 location

▼ -1 trial since August 2026

Also known as: Myrbetriq

Pipeline

Phase 2: 2

Top Sponsors

  • Zhejiang Provincial People's Hospital1
  • Philip Kern1

Indications

  • PreDiabetes1
  • DLBCL - Diffuse Large B Cell Lymphoma1
  • Diabetes1
  • SCLC1
  • TNBC - Triple-Negative Breast Cancer1

Other1 trial

Milaberon in Advanced Solid Tumors: an Open, Multicenter Clinical Study
Phase 2

Lexington, Kentucky1 trial

Mechanisms for Activation of Beige Adipose Tissue in Humans

University of Kentucky

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.